A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Table S1
For the wider context on how hormones, blood flow, and body weight intersect, see our complete Sexual Health Hub
Ozempic may also help you lose weight
Sermorelin is a peptide that may support the bodys natural growth hormone production, which plays a role in metabolism, lean tissue maintenance, and recovery
https Related Reading Best Time of Day to Take Semaglutide for Weight Loss Does GLP-1 Make You Tired How Long Does It Take for GLP-1 to Work GLP-1 Dosage for Weight Loss GLP-1 Constipation How Long Does It Take for Semaglutide to Suppress Appetite How Do I Find Out Which GLP-1 Drug is Right for Me